Provepharm Inc. 2024-12-25 Health serious FDA
Health · FDA · Recall #FDA-D-0150-2025
Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx… Recall
Issued December 25, 2024 · Provepharm Inc.
In December 2024, Provepharm Inc. recalled the Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Discoloration
What you should do
- 1 Stop using Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Provepharm Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Provepharm Inc.
- Category
- Health
- Recall date
- December 25, 2024
- Units affected
- Not reported
- Sold at
- Nationwide within the United States
- Recall number
- FDA-D-0150-2025
- Made in
- United States
- Issuing agency
- FDA
In context
- Provepharm Inc. has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.